Cite Filings / IKT
Feed Companies Filings Check
Sign in

CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company

Inhibikase Therapeutics, Inc.

Sign in to watch
Ticker
IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
263407249
Phone
(302) 295-3800
Business address
1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
Filings Insiders Search text
All 370 Financials 97 Shareholder Meetings 15 Executive Compensation 87 Insider Trading 112 Beneficial Ownership Interest 48 Business Combinations 71 Public Offerings 66 Mutual Funds and ETFs 8 Others 40
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-30
  3. PRE 14A Proxy Proxy Statement (Preliminary) 2026-04-20
  4. DEF 14A Proxy Proxy Statement 2025-05-12
  5. PRE 14A Proxy Proxy Statement (Preliminary) 2025-05-02
  6. DEF 14A Proxy Proxy Statement 2024-11-18
  7. PRE 14A Proxy Proxy Statement (Preliminary) 2024-11-08
  8. DEF 14A Proxy Proxy Statement 2024-06-20
  9. PRE 14A Proxy Proxy Statement (Preliminary) 2024-06-10
  10. DEF 14A Proxy Proxy Statement 2024-04-26
  11. PRE 14A Proxy Proxy Statement (Preliminary) 2024-04-15
  12. DEF 14A Proxy Proxy Statement 2023-05-05
  13. PRE 14A Proxy Proxy Statement (Preliminary) 2023-04-21
  14. DEF 14A Proxy Proxy Statement 2022-05-02
  15. PRE 14A Proxy Proxy Statement (Preliminary) 2022-04-21
  16. DEF 14A Proxy Proxy Statement 2021-04-30

Page 1 of 1 · 15 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…